C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/85 (2006.01) A61K 31/70 (2006.01) A61K 39/12 (2006.01) A61K 39/21 (2006.01) C07K 14/16 (2006.01) C12N 15/867 (2006.01) C12N 15/87 (2006.01) A61F 13/00 (2006.01) A61K 39/00 (2006.01)
Patent
CA 2102918
An approach to vaccine methodology is described which is based on a genetic vaccine for a virus. A genetic construction encoding antigenic determinants of the virus is transfected into cells of the vaccinated individuals so as to express the viral antigens in healthy cells to produce an immune response to those antigens. The method is particularly advantageous for the HIV virus.
Agracetus Inc.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
Powderject Vaccines Inc.
LandOfFree
Genetic vaccine for immunodeficiency viruses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Genetic vaccine for immunodeficiency viruses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Genetic vaccine for immunodeficiency viruses will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1643698